Heidi, an AI tool for clinicians that has become deeply embedded within the UK’s National Health Service (NHS), has closed a $65 million Series B funding round. The round, led by Point72 Private Investments, values the company at $465 million and brings its total funding to nearly $100 million.
The company’s AI platform acts as a "care partner" for doctors, automating administrative tasks like clinical documentation and follow-up communications. Its traction is undeniable: according to the company, Heidi is already used by over 60% of NHS General Practitioners (GPs), supporting more than 340,000 patient consultations every week and saving an estimated 3 million clinical hours annually in the UK alone.
This isn't just about GP offices. The new funding is set to accelerate Heidi’s expansion into secondary care and global markets. The company has already secured a major deployment with Modality Partnership, the NHS’s largest GP super-partnership, and is running pilots with major hospital groups, including Cambridge University Hospitals and NHS Trusts serving millions in London and Lancashire.
From GPs to global expansion
While its NHS footprint is its anchor, Heidi’s global reach is expanding rapidly. The company reports supporting over two million patient consultations a week across 116 countries and in 110 languages. Over the last 18 months, it claims to have supported 73 million patient consults globally.
"It is untenable that healthcare demand continues to rise while clinical time continues to shrink," said CEO and co-founder Dr. Thomas Kelly in a statement. He positions Heidi as a tool to expand clinical capacity without compromising clinician wellbeing.